Skip to main content

Peer Review reports

From: Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Original Submission
2 Apr 2017 Submitted Original manuscript
8 Aug 2017 Reviewed Reviewer Report - Katherine Tkaczuk
16 Aug 2017 Reviewed Reviewer Report - Ioannis Voutsadakis
5 Sep 2017 Reviewed Reviewer Report - Bora Lim
8 Oct 2017 Author responded Author comments - Sakura Iizumi
Resubmission - Version 2
8 Oct 2017 Submitted Manuscript version 2
27 Oct 2017 Reviewed Reviewer Report - Bora Lim
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Nov 2017 Editorially accepted
4 Dec 2017 Article published 10.1186/s12885-017-3846-8

You can find further information about peer review here.

Back to article page